ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,491Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 131

$594K Total Retail Price of All Prescriptions

Rank: 23 out of 131

392 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 392 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 392 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 9,991 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LOSARTAN POTASSIUM 426 385 1 21
SIMVASTATIN 425 377 2 1
FAMOTIDINE 368 318 3 44
AMLODIPINE BESYLATE 367 335 4 2
METOPROLOL SUCCINATE 319 297 5 10
FUROSEMIDE 296 262 6 3
DONEPEZIL HCL 295 295 7 17
MELOXICAM 295 280 7 39
METOPROLOL TARTRATE 260 244 9 7
CLOTRIMAZOLE-BETAMETHASONE 233 213 10 61
SILVER SULFADIAZINE 229 195 11 105
ENALAPRIL MALEATE 225 216 12 18
OMEPRAZOLE 223 197 13 4
METFORMIN HCL 218 172 14 8
NAMENDA 207 195 15 26
NEXIUM 202 166 16 16
MIRTAZAPINE 174 174 17 34
ZOLPIDEM TARTRATE 166 148 18 15
WARFARIN SODIUM 163 137 19 9
LEVETIRACETAM 161 124 20 37
LEVOTHYROXINE SODIUM 158 132 21 5
PLAVIX 154 144 22 36
QUETIAPINE FUMARATE 137 129 23 43
LOSARTAN-HYDROCHLOROTHIAZIDE 123 108 24 58
TRAMADOL HCL 122 90 25 31
DIOVAN 116 116 26 30
BYSTOLIC 105 103 27 118
NIFEDIPINE ER 104 93 28 111
RISPERIDONE 103 94 29 42
CLOPIDOGREL 102 96 30 28
TRAMADOL HCL-ACETAMINOPHEN 95 89 31 92
TAMSULOSIN HCL 95 77 31 24
LISINOPRIL 94 91 33 6
HYDROCODONE-ACETAMINOPHEN 89 51 S3 34 13
SEROQUEL 87 76 35 91
LACTULOSE 86 72 36 54
JANUVIA 83 77 37 32
AMLODIPINE BESYLATE-BENAZEPRIL 83 76 37 66
SSD 81 78 39 115
ATENOLOL 81 71 39 14
CARBIDOPA-LEVODOPA 78 61 41 60
HALOPERIDOL 76 48 42 88
DIGOXIN 75 75 43 49
POLYETHYLENE GLYCOL 3350 72 63 44 47
SYMBICORT 71 51 45 146
NEOMYCIN-POLYMYXIN-DEXAMETH 67 61 46 290
ACTOS 67 64 46 202
PREDNISONE 66 50 48 51
BENZTROPINE MESYLATE 64 15 R 49 97
GABAPENTIN 61 42 50 20
SPIRONOLACTONE 58 49 51 86
GLIPIZIDE XL 57 53 52 102
AMITRIPTYLINE HCL 55 34 R 53 207
ATORVASTATIN CALCIUM 54 54 54 11
LEVOFLOXACIN 52 44 55 96
CITALOPRAM HBR 51 51 56 22
TRAZODONE HCL 50 30 57 40
ADVAIR DISKUS 50 27 57 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.